Clinical Cancer Research Targets Advances in Breast Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Clinical Cancer Research 14, 6839, November 1, 2008. doi: 10.1158/1078-0432.CCR-08-0230
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lutgendorf, S. K.
Right arrow Articles by Sood, A. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lutgendorf, S. K.
Right arrow Articles by Sood, A. K.

Human Cancer Biology

Biobehavioral Influences on Matrix Metalloproteinase Expression in Ovarian Carcinoma

Susan K. Lutgendorf1,2,3,4, Donald M. Lamkin1, Nicholas B. Jennings6, Jesusa M.G. Arevalo8, Frank Penedo10,12, Koen DeGeest2, Robert R. Langley6, Joseph A. Lucci, III11,12, Steve W. Cole8,9, David M. Lubaroff3,4,5 and Anil K. Sood6,7

Authors' Affiliations: Departments of 1 Psychology, 2 Obstetrics and Gynecology, and 3 Urology and 4 Holden Comprehensive Cancer Center, University of Iowa; 5 Department of Microbiology, University of Iowa, and Department of Veterans Affairs Medical Center, Iowa City, Iowa; Departments of 6 Gynecologic Oncology and 7 Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; 8 Division of Hematology-Oncology, David Geffen School of Medicine, University of California at Los Angeles School of Medicine; 9 The Norman Cousins Center, Jonsson Comprehensive Cancer Center, University of California at Los Angeles AIDS Institute, and University of California at Los Angeles Molecular Biology Institute, Los Angeles, California; and 10 Department of Psychology and 11 Division of Gynecologic Oncology and 12 Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida

Requests for reprints: Susan K. Lutgendorf, Department of Psychology, University of Iowa, E11 Seashore Hall, Iowa City, IA 52242. Phone: 319-335-2432; Fax: 319-335-0191; E-mail: susan-lutgendorf{at}uiowa.edu.

Purpose: Stromal cells in the tumor microenvironment, such as macrophages, play an active role in tumor growth and angiogenesis. However, little is known about relationships of biobehavioral factors with angiogenic cytokines and matrix metalloproteinases (MMP) produced by stromal cells. This study examined distress, MMPs, and angiogenic cytokines in ovarian cancer patients and in vitro.

Experimental Design: Patients suspected of ovarian cancer completed preoperative questionnaires. At surgery, 56 were confirmed to have epithelial ovarian cancer. Tumor samples were analyzed for macrophage (CD68+) and tumor cell levels of MMP-2, MMP-9, and vascular endothelial growth factor. In vitro stimulation of isolated macrophage cells by the stress hormones norepinephrine and cortisol was done to assess effects on MMP-9.

Results: Depressed patients showed significant elevations of MMP-9 in CD68+ cells, adjusting for stage (P < 0.0001). Patients with higher levels of current stress (P = 0.01), life stress over the last 6 months (P = 0.004), and general negative affect (P = 0.007) also showed significantly greater MMP-9 in CD68+ cells. In contrast, higher social support was associated with lower levels of MMP-9 (P = 0.023) and vascular endothelial growth factor (P = 0.036) in tumor cells. In vitro analyses showed that macrophage MMP-9 production could be directly enhanced (up to a 2-fold increase) by the stress hormones norepinephrine and cortisol.

Conclusions: Ovarian cancer patients with elevated depressive symptoms, chronic stress, and low social support showed elevations in MMP-9 in tumor-associated macrophages. Direct in vitro enhancement of stromal MMP-9 production by stress hormones was also shown. These findings may have implications for patient outcomes in ovarian cancer.




This article has been cited by other articles:


Home page
Cancer Res.Home page
D. Chakroborty, C. Sarkar, B. Basu, P. S. Dasgupta, and S. Basu
Catecholamines Regulate Tumor Angiogenesis
Cancer Res., May 1, 2009; 69(9): 3727 - 3730.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
K. E. Freedland, E. J.C. de Geus, R. N. Golden, W. J. Kop, G. E. Miller, V. Vaccarino, B. Brumback, M. M. Llabre, V. J. White, and D. S. Sheps
What's in a Name? Psychosomatic Medicine and Biobehavioral Medicine
Psychosom Med, January 1, 2009; 71(1): 1 - 4.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.